This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Cardiovascular Associates of America, backed by Webster Equity Partners, currently includes practices in eight different states. Its partner cardiologists now have preferred access to multiple cloud-based services provided by Athenahealth.
AI transparency in medical devices is achievable and imperative, according to new guidance jointly promoted by the FDA, Health Canada and the U.K.’s Medicines and Healthcare products Regulatory Agency.
The new algorithm from Implicityevaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.
The Rand Corporation is reporting that, in 2022, employers and private insurers paid hospitals an average 254% more than what Medicare would have spent for the same services in the same facilities.
Four of five hospital leaders trust the accuracy of their institution’s data. Yet almost half of useable data gets underutilized if not completely untapped for guiding business and clinical decisions.
Medicare’s Hospital Insurance (HI) Trust Fund has the wherewithal to pay the full bill for beneficiaries’ stays in hospitals, hospice sites and skilled nursing facilities for the next 12 years. But what then?
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
Cardiovascular Associates of America, backed by Webster Equity Partners, currently includes practices in eight different states. Its partner cardiologists now have preferred access to multiple cloud-based services provided by Athenahealth.
The American Society of Nuclear Cardiology (ASNC) supports an AMA policy that condemns the use AI to make prior authorization decisions rather than a doctor or clinician.